Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$56.55 - $66.59 $56,550 - $66,590
1,000 Added 11.63%
9,600 $546,000
Q4 2023

Feb 02, 2024

BUY
$52.16 - $64.19 $448,575 - $552,034
8,600 New
8,600 $539,000
Q1 2023

May 12, 2023

SELL
$70.23 - $86.01 $189,621 - $232,227
-2,700 Reduced 48.21%
2,900 $209,000
Q4 2022

Feb 14, 2023

SELL
$67.18 - $84.11 $107,488 - $134,576
-1,600 Reduced 22.22%
5,600 $449,000
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $191,922 - $240,294
2,900 Added 67.44%
7,200 $480,000
Q2 2022

Aug 11, 2022

BUY
$66.18 - $83.18 $284,574 - $357,674
4,300 New
4,300 $327,000
Q4 2018

Jan 22, 2019

SELL
$58.5 - $69.94 $181,350 - $216,814
-3,100 Closed
0 $0
Q3 2018

Oct 29, 2018

SELL
$61.75 - $74.23 $6,175 - $7,423
-100 Reduced 3.13%
3,100 $214,000
Q2 2018

Jul 25, 2018

BUY
$60.85 - $83.98 $36,510 - $50,388
600 Added 23.08%
3,200 $214,000
Q1 2018

May 08, 2018

BUY
$83.06 - $100.98 $33,224 - $40,392
400 Added 18.18%
2,600 $217,000
Q4 2017

Feb 14, 2018

BUY
$93.56 - $116.6 $205,832 - $256,520
2,200
2,200 $208,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Intact Investment Management Inc. Portfolio

Follow Intact Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intact Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Intact Investment Management Inc. with notifications on news.